CXCR4 and neoplasm: Pharmacological inhibition of CXCR4 using AMD3100 to prevent PvTAM accumulation reduced tumor recurrence in a murine Lewis Lung carcinoma model post cyclophosphamide treatment [17], providing a therapeutic strategy to block these effects.